Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Infections after the use of alemtuzumab in solid organ transplant recipients: a comparative study.

Safdar N, Smith J, Knasinski V, Sherkow C, Herrforth C, Knechtle S, Andes D.

Diagn Microbiol Infect Dis. 2010 Jan;66(1):7-15. doi: 10.1016/j.diagmicrobio.2009.08.017.

PMID:
19963164
2.

Statins are associated with improved outcomes of bloodstream infection in solid-organ transplant recipients.

Hsu J, Andes DR, Knasinski V, Pirsch J, Safdar N.

Eur J Clin Microbiol Infect Dis. 2009 Nov;28(11):1343-51. doi: 10.1007/s10096-009-0787-4. Epub 2009 Aug 9.

PMID:
19669657
3.

Voriconazole therapeutic drug monitoring.

Smith J, Safdar N, Knasinski V, Simmons W, Bhavnani SM, Ambrose PG, Andes D.

Antimicrob Agents Chemother. 2006 Apr;50(4):1570-2.

4.

Predictors and outcomes of candiduria in renal transplant recipients.

Safdar N, Slattery WR, Knasinski V, Gangnon RE, Li Z, Pirsch JD, Andes D.

Clin Infect Dis. 2005 May 15;40(10):1413-21. Epub 2005 Apr 12.

PMID:
15844063
5.

The direct costs of nosocomial catheter-associated urinary tract infection in the era of managed care.

Tambyah PA, Knasinski V, Maki DG.

Infect Control Hosp Epidemiol. 2002 Jan;23(1):27-31.

PMID:
11868889

Supplemental Content

Loading ...
Support Center